Search Results

coupled receptors (GPCRs) in breast cancer, and his interest in pancreatic cancer. biology led him to transition into using mouse models. They also shared their personal experiences and interest in the field of biology. as a potential drug target due to its high expression in triple negative breast cancer. Mike then transitioned to pancreatic cancer, questioning why genes are dysregulated in cancer, which

Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule G Proteins and GPCRs in Cancer Department of Pharmacology, School of Medicine, and Associate Director for Basic Science at the Moores Cancer treatments, and to identify novel multimodal strategies to enhance the response to cancer immunotherapies Silvio Gutkind on the web Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications Pubmed LinkedIn Twitter UCSD Moores Cancer Center Dr.

to schedule Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer

Stephen, Caron Kathleen M Department of Cell Biology and Physiology at UNC Chapel Hill 111 Mason Farm Van Meir’s research examines how genetic alterations and hypoxia induce changes in cell biology that : Department of Biology, Ashoka University. Currently: University of Leipzig Mansi Tiwari: Department of Biology, Ashoka University. I joined the Department of Biology at Ashoka University in 2020 as an assistant professor."

Institute for Diabetes and Cancer, Helmholtz Centre Munich, Germany, 2. Centre for Experimental Medicine, Institute for Biocehmistry and Molecular Cell Biology, University Medical Centre, Munich 2015 - 2018 Postdoctoral fellow, Department of Adipose Tissue Biology, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich 2012 - 2015 Postdoctoral fellow, Department of Cell and Molecular Biology, Karolinska Institute, Sweden" Anastasia Georgiadi on the web Endocrine Pharmacology

Hailey Steichen, Krystin Eaton, Teagan Yan, and Nathan Zaidman; Department of Biochemistry and Molecular Biology Jianxiang Xue "I am a postdoctoral researcher working in the Department of Biochemistry and Molecular Biology Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL, USA; 2. Current affiliation: Department of Structural Biology, Genentech, South San Francisco, CA, USA" About Vincent 3, Leduc Richard 4, Olivares-Reyes Jesús Alberto 2, Boucard Antony A1. 1 Department of Cell Biology

Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain and Belgium, and subsequently as a cell biologist during my postdoc (2006-2011) with Dr. Marilyn Farquhar (UC, San Diego), a pioneer of modern Cell Biology. To achieve this goal, we use a wide range of established approaches (biochemistry, cell biology, genetics Our ongoing efforts have direct implications in cancer, embryonic development defects, and neurological

The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers Cardarelli is a drug development leader with extensive experience driving drug discovery teams in bringing biologics She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience

joined in April 2020, following three years on the editorial teams of Nature Structural and Molecular Biology Weill Cornell Graduate School of Medical Sciences in New York City, studying epigenetic changes in cancer Katarzyna handles submissions in structural biology, biophysics and biochemistry, with a particular focus

control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR biology research has focused on PAR1, which has important functions in hemostasis, thrombosis, inflammation, and cancer protease-activated receptors, particularly PAR1, and over the years she has discovered novel aspects of GPCR biology

There, I investigated Two-Pore-Potassium channels using electrophysiology, molecular and chemical biology from discovery to preclinical candidate nomination and to provide the tools to advance adhesion GPCR biology Sabbagh undertook post-doctoral fellowships at the Ontario Cancer Institute and the University of Toronto projects aimed on drug discovery of small molecules for the treatment of inflammatory disorders and cancer Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology

Sri Kosuri Sri is a biologist that has helped build technologies, labs, and companies in synthetic biology He is passionate about developing more rational ways to understand and engineer biology. empirically exploring questions in protein biochemistry, human genetic variation, gene regulation, chemical biology , synthetic biology, and functional genomics. He is a Searle Scholar (2015), NIH New Innovator (2014), and received his ScD in Biological Engineering

A large component of his work is centered around dysregulated signaling in cancer and the development of novel mechanism-based cancer therapies. Silvio Gutkind on the web Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications More J Silvio Gutkind on LinkedIn Gutkind Lab on Twitter UCSD Moores Cancer Center Dr.

Professor at the University Autonomous of Madrid (UAM) and she has been Academic Secretary of Molecular Biology Catalina Ribas, located in the Centro de Biología Molecular “Severo Ochoa” (UAM/CSIC) and belongs also (GRK2), a known regulator of Gq-GPCR signaling in HNSCC tumor progression (International Journal of Cancer , 2020). " Catalina Ribas on the web Severo Ochoa Molecular Biology Center X (Twitter) Dr.

Conformational Landscapes Rajan Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Position - Autonomous University of Barcelona GPCR Molecular Pharmacologist - Schrödinger Scientist - Biology - Superluminal Medicines Scientist I Cell Biology - Tectonic Therapeutic Adhesion GPCRs A force-sensitive mediators of tumour-to-TME crosstalk Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer ligand recognition and biased signaling in the motilin receptor 🔎 GPCR KEYWORDS GPCR , structural biology

In this episode, Silvio discusses G protein signaling in the context of cancer, immunotherapies, and J Silvio Gutkind on LinkedIn Gutkind Lab – UC San Diego Moores Cancer Center Gutkind Lab publications Gutkind Lab on Pubmed Gutkind Lab on Twitter UCSD Moores Cancer Center Dr.

He also worked on creating novel methods for systems biology using temporal logic specifications while Integrating Mathematical Models and Biology: A Fascinating Discussion Yamina and Aurelien Rizk had a conversation about the importance of merging mathematical models and biology. They highlighted that while there was a time when biology lagged due to the lack of appropriate tools and relevance of mathematical models in systems biology and pharmacology.

Transcript Variants in Mouse Kidney Hailey Steichen Elucidating The Role Of GPR97/ADGRG3 In Neutrophil Biology Heart and Lung Research, Ludwigstrasse 43, 61231 Bad Nauheim, Germany 3 Department of Developmental Biology He has received his BSc and MS degree from the Department of Biochemistry and Molecular Biology, University Authors & Affiliations "Department of Biochemistry & Molecular Biology, University of New Mexico Health I received my MS in Applied Toxicology from the University of Washington, and my BA in Biology from Vassar

me to shape a swiss start-up company from a scientifc idea to a thriving Biotech focusing on Systems Biology control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR biology research has focused on PAR1, which has important functions in hemostasis, thrombosis, inflammation, and cancer protease-activated receptors, particularly PAR1, and over the years she has discovered novel aspects of GPCR biology

Potent inhibitors of ADO signaling are currently being tested in cancer patients, including in randomized immunologist, Dr Stagg is recognized for having identified the adenosine-producing enzyme CD73 as a new cancer John Stagg on the web University of Montréal Québec Cancer Consortium The University of Montreal Hospital

Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology Eldridge Distinguished Professor and Chair of the Department of Cell Biology & Physiology at The University Caron received a BS in Biology and BA in Philosophy at Emory University and a PhD at Duke University Cancer Center Twitter Google Scholar ORCID ResearchGate Dr. Integrating GPCR biology, behavioral pharmacology, and systems neuroscience approaches, the Slosky Lab

for GPCR Papers Special Issue on Adhesion GPCRs Read More November 1, 2024 Emerging Voices in GPCR Biology 2025 SIGMAR1 screened by a GPCR-related classifier regulates endoplasmic reticulum stress in bladder cancer Read More April 7, 2025 G-protein coupled receptors in metabolic reprogramming and cancer Read More Biomarker in Sarcoma Read More Methods & Updates in GPCR Research April 18, 2025 Structural Systems Biology

Pharmacology, Career Twists & Serendipity with Sokhom Pin In this episode, we welcome Sokhom Pin , Head of Biology His early work focused on prostate cancer research, including 22 autopsies during night shifts—an experience

Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology Melbourne Australia, GPCR pharmacology; 2006) before starting his independent research team "Receptor Biology Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological is on Frizzled signaling and pharmacology aiming to understand the role of WNT/Frizzled signaling in biology

Monserrat Avila Zozaya I did a PhD in cell biology at CINVESTAV, Mexico. During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the About John Azietaku John Teye Azietaku,PhD is a trained pharmacist, holding a Ph.D. in Drug Discovery Biology

Join the GPCR Retreat: Exploring the Frontiers of GPCR Biology! world-class and diverse GPCR scientists working in the arenas of structure and signaling, neuroscience, cancer